Epidermal growth factor (EGF) is a 53-amino acid polypetide which is a potent mitogen for cultured cells. The kidney has recently been shown to be a major site of synthesis for the EGF precursor. EGF infusions in sheep result in a diuresis and natriuresis despite a fall in GFR, suggesting a direct tubular effect. Using in vitro microperfusion of rabbit cortical collecting tubules (CC1s) at 370C, we examined the effect of EGF on the transepithelial voltage (VJ) and arginine vasopressin (AVP)-stimulated hydraulic conductivity (Lp). Pretreatment with peritubular EGF at concentrations from lo-8 to 10-12 M resulted in a 50% inhibition of both AVP-and 8-chlorophenythio-cyclic AMP-stimulated peak Lp. This effect was reversed by the protein kinase C inhibitor, staurosporine, but unaffected by indomethacin. CCTs with an initially negative V,, depolarized after exposure to bath EGF. 10-8 M EGF applied from the lumen had no effect on either Lp or Vt. Specific binding of 20 nM 125I-EGF to microdissected CCITs was also demonstrated. These results suggest that EGF can modulate both salt and water transport in the CCI via a receptor linked to protein kinase C activation.
Introduction
Epidermal growth factor (EGF)' was originally isolated from extracts of mouse submaxillary gland as the active agent that induced precocious eyelid opening and early incisor eruption in newborn mice (1) . Since then EGF has been demonstrated to be a potent mitogen in a wide variety of cultured epithelial and mesenchymal cells (2) . Several intracellular events that precede or accompany this proliferative response, including activation of Na+/H' exchange (3) and stimulation of tyrosine kinase activity (4) , have also been described.
Although the cellular actions of EGF have been extensively studied, relatively little is known about the precise physiologic (5) . The high levels of EGF in urine relative to blood suggested that the kidney itself may be the source of urinary EGF (7) . In support of this, Rall and co-workers have recently demonstrated that the kidney is a major site of synthesis for the EGF precursor, preproEGF (8, 9) . PreproEGF mRNA levels in the thick ascending limb of Henle and distal convoluted tubules of the kidney are orders of magnitude higher than in other tissues.
The function of the EGF precursor in the distal nephron remains a matter of speculation. Specific receptors for EGF in whole-kidney homogenates are well described (10) , and more recently their existence has been demonstrated in numerous cultured kidney cells (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and in suspensions of collecting duct cells. Scoggins et al. (14) found that EGF infusion in sheep caused a brisk naturesis and diuresis despite a fall in GFR. Taken together these findings suggest the possibility that EGF might have an effect on vasopressin-stimulated water reabsorption in the collecting duct. In the present studies, we examined the effects of EGF on the hydroosmotic response to vasopressin in the isolated microperfused rabbit cortical collecting tubule (CCT). We observed potent effects of EGF on both arginine vasopressin (AVP)-stimulated water flow and transepithelial voltage in the CCT.
Methods

Microperfusion experiments
Single CCTs (1.61±0.05 mm in length) were dissected from kidneys of female New Zealand White rabbits weighing between 1.5 and 2.0 kg. After isolation, the CCT was transferred to a thermostatically controlled, flowing bath chamber, cannulated, and perfused with an isotonic solution as previously described (15) . An isotonic bath solution was also used and bath flow Was adjusted to 0.5 ml/min using a perfusion pump (Sage Instruments, Inc., Cleveland, OH). The hydrostatic pressure of the perfusate was adjusted so luminal fluid was collected at a rate of 15-23 nl/min into a constriction pipette of known volume (four pipettes used, ranging from 65 to 107 nl). Transepithelial voltage (VJ) was continuously monitored by electometer (FD-223, World Precision Instruments, New Haven CT) and strip chart recorder (model R-02, Soltec Co., Sun Valley, Ca.).
Experimental design
All experiments were performed at 370C. After an initial equilibration period of 45 min the isotonic perfusate was exchanged with a hypotonic solution (150 mosmol) containing exhaustively dialyzed tritiated inulin. The seven following protcols were conducted.
Control studies with A VP or 8-chlorophenylthio-cyclic AMP (CcAMP).2 30 min after the perfusate exchange, three collections were taken for the determination ofbasal CCT hydraulic conductivity (Lp). Tubules with negative basal Lp values significantly less than zero (< -4.0 X 10-cm/atm per s) were presumed to have an inulin leak and were discarded. Immediately after basal measurements were taken, 10 MU/ml AVP or 0.1 mM CcAMP was added to the bath. We chose to use this dose of AVP since it is above the maximal physiologic concentration of AVP measured in the rabbit ( 16) . This concentration might also allow us to see either suppression or stimulation of AVPinduced Lp (17) .
A 10-1 5-min equilibration period was allowed and then six to eight collections were taken for the determination of peak Lp response to AVP or CcAMP. The peak Lp was defined as the mean of the three greatest contiguous values obtained after exposure to AVP or CcAMP. Preliminary studies showed this peak generally occurred 30-45 min after exposure to these agents.
Effect ofperitubular EGF on A VP-stimulated Lp in the CCT. 15 min after the perfusate exchange, varying concentrations of EGF were added to the bath. Another 15-min equilibration period was allowed to elapse before the three collections for basal Lp were made. After basal collections, the 10 MU/ml AVP was added to the EGF-containing bath. The total elapsed time before the tubule was exposed to AVP was thus identical to that in the control group. A 10-min equilibration period was allowed and six to eight collections for peak Lp were made.
Effect ofperitubular 3. 10-10 M EGF on CcAMP-stimulated Lp in the CCT Since AVP stimulates osmotic water flow via a cAMP-dependent mechanism, we examined the effects of EGF on CcAMPstimulated Lp. These studies were intended to distinguish an effect of EGF on cellular cAMP levels versus processes stimulated by cAMPdependent mechanisms. The protocol was designed precisely as the previous experiment except tthat, after basal Lp collections, 0.1 mM CcAMP was added to the EGF-containing bath instead of AVP. Peak Lp was then determined.
Effect ofluminal EGF on A VP-stimulated Lp. Because ofevidence, reviewed in the discussion, that EGF is secreted into the urine, we examined the effect of luminal EGF on AVP-stimulated Lp. After a 45-min equilibration period, the isotonic perfusate was exchanged for hypotonic perfusate containing 0.1% albumin (to serve as a carrier) and 3 * 108 M EGF. A 30-min equilibration period was allowed before basal Lp measurements were made. The tubule was then exposed to 10 ,uU/ml AVP and peak Lp was determined.
Effect ofindomethacin (INDO) pretreatment on the EGF-mediated inhibition ofA VP-stimulated Lp. 5 min after the hypotonic perfusate exchange was made, 5 uM INDO was added to the bath. This concentration of INDO was chosen since it has previously been shown to inhibit cyclooxygenase almost completely, have little effect on cAMP phosphodiesterase (18) , and to reverse the inhibitory effects of both bradykinin (19) Effect of EGF on V,. Although these studies were primarily designed to examine the effect of EGF on the response of the CCT to AVP, we noted striking changes in the Vt after the tubule was exposed to EGF. Comparison between the change in Vt (AVt) for control tubules versus EGF-treated tubules were made at identical time points for all experiments. AV, was defined as the change in Vt between two time points: 10 min after the perfusate exchange (i.e., 5 min before EGF was added to the bath in experimental tubules) and at the beginning of the first collection for basal Lp (i.e., 15 min after exposure to EGF in the experimental tubules). We also compared the peak hyperpolarization of Vt in response to AVP with and without EGF. Comparison was made by nonpaired t test.
Solutions
The composition of the bath medium, and isotonic perfusate was (in millimolar): NaCl 105, NaHCO3 25, Na acetate 10, NaHPO4 2.3, KCl 3 .0 NaH2PO4, 90 NaCl, 5 KCI, 2 MgSO4, 1 CaCI2. In addition, bovine serum albumin (0.5% wt/wt), bacitracin (0.08%), and aprotinin (15 MM) were added to diminish proteolysis of the receptor and 1251I-EGF as well to diminish nonspecific binding. 36-45 CCTs per experiment were microdissected and their length determined by an eyepiece reticle. Tubules were arranged into six groups, each containing 9-13 mm of CCTs, and each group was transferred onto a small albumin-coated aluminum foil disc that was in a well of an aluminum plaque as described by Mujais et al. (23) . Three wells were used to measure total binding and three wells for nonspecific binding. The microdissection solution was aspirated and replaced with 2 Ml of chilled incubation solution which was identical except for the addition of the radiolabled and unlabeled EGF. Three additional wells containing foil but no tubules were also exposed to '25I-EGF and counted as blanks.
In separate studies (24) , experiments were performed in microdissected pars rectae to determine the optimal temperature, hormone concentration, and incubation time for the binding assay. These studies showed equilibrium binding on ice to occur within 4 h, specific '25I-EGF binding to be saturable (apparent Kd = 6.5 nM) and not competed offby other polypeptides. Based on these results, incubation ofthe microdissected CCTs was performed on ice (to prevent receptor internalization), for 4 h and using 20 nM '251I-EGF with (nonspecifi? binding) or without (total binding) a 500-fold excess of noniodinated EGF. By means of a dissecting microscope, the incubation medium was then aspirated and the 5 ul of wash buffer was added. This wash procedure was repeated for each well four times. The foil discs were then counted for 10 min using an Isodyne model 1185 automatic gamma system (TM Analytic, Inc., Elk Grove Village, IL).
125I-EGF binding was calculated in attomoles per centimeter as equal to: { [counts/well(total or nonspecific)-blk]/ 10 min/tubule length in cm} (attomoles '25I-EGF/cpm). Attomoles bound '251-EGF/cpm were determined using the counting efficiency of the counter (0.48 cpm/dpm), the specific activity of the '251-EGF (-170 15) had basal Lp values of 6.8±2.7, which increased to a peak value 232.4±9.6 after AVP addition. Tubules pretreated with doses of EGF ranging from 3 X 10-12 to 3 X 10-8 M demonstrated no significant difference in basal Lp (11.6±3.2) from the control group (P > 0.1); however, AVP-stimulated Lp in EGF-pretreated tubules was significantly lower over this dose range of EGF (e.g., 3 X 10-12 M EGF, n = 5, peak Lp = 142.9±20.27, P < 0.0005 vs. control). EGF also caused the AVP-stimulated peak Lp to occur significantly earlier than in the control group (AVP peak at 54.8±1.78 min after AVP and EGF/AVP peak 31.4±1.34 min after AVP, P < 0.0005). Nevertheless, at 31 min the Lp response to AVP was higher than in the EGF/AVP group (AVP 31 min = 178±10.65 vs. EGF/ AVP 31 min = 117±8.88, P < 0.0005). When the dose ofEGF was further decreased to 3 X 10-'`M, these effects were lost (n = 4, peak Lp = 221 ± 19.4, P > 0.1 vs. control group).3 Thus the inhibitory effect of EGF pretreatment on AVP-stimulated LuminalEGF has no effect on A VP-stimulatedLp. Because of the possibility that EGF is secreted into the urine and is in contact with the tubular cell luminal membrane, we examined the effects of luminal EGF on AVP-stimulated Lp. Pretreatment with 3 X 10-8 M luminal EGF had no effect on either basal or AVP-stimulated peak Lp (-1. 18±.98 and 239.8±31.1, respectively, p > 0.1 vs. control) (Fig. 1) .
Inhibitory effect ofperitubular EGF on CcAMP-stimulated Lp. Pretreatment of CCTs with peritubular EGF (10-10 M) resulted in a 42% reduction in CcAMP-stimulated Lp (132.2±17.43, n = 6, vs. 225.8±25.2 in CcAMP control group, n = 6, P < 0.01). The magnitude ofthis inhibition of CcAMPstimulated Lp was comparable to that observed for the AVPstimulated water flow (42% vs. 50% inhibition) (Fig. 2) . (Fig. 2) (27) . Within 5 min of exposing CCTs (used in the previously described water flux studies) to peritubular EGF, we observed a reproducible depolarization of the lumen-negative 'V (Fig. 3) . No deterioration in tubule morphology was noted. Using the parameter A V, as defined in Methods we compared the change in Vt between EGF-treated and nontreated tubules over comparable time points. AV t in control tubules was -1.7±0.66 mV in control tubules (n = 23) and +8.9±1.9 mV in tubules exposed to EGF over the dose range seen to inhibit AVP-stimulated Lp (i.e., 10-8 to 10-12 M EGF, n = 24, P < 0.0005). Luminal addition of EGF had no effect on Vt. Thus there is a highly significant and rapid effect of peritubular EGF on AVt in the CCT.
AVP is known to cause a transient hyperpolarization in the CCT (26) . Control tubules hyperpolarized by -6.8±1.14 mV in response to AVP. The AVP-induced hyperpolarization peak was not prevented by EGF (mean voltage hyperpolarization -4.52±0.94, P = ns vs. controls). (Fig. 4) .
Discussion
The present studies represent the first demonstration of a direct renal tubular action of EGF. These studies are of particu- lar significance since the kidney appears to be a major site of synthesis for the EGF precursor prepro-EGF. EGF has been shown to be mitogenic in a variety of cultured cells including renal epithelial cells (1 1, 13, 28) . However, the relevance ofthe mitogenic effects of EGF on cultured cells to its role in the intact animal is uncertain. For example insulin, bradykinin, and AVP are also mitogenic in cultured cells (28, 29) yet in vivo their primary roles are not as growth factors. The demonstration of acute functional effects of EGF on the CCT, freshly obtained from the in vivo setting, provides important new information. Since this tissue is not actively proliferating, these findings raise the possibility that, in a manner analogous to AVP or insulin, EGF might function not only as a growth factor, but may play a dual role in the intact animal, modulating both transport and growth.
The first evidence that EGF might modulate renal tubular transport was obtained in conscious sheep, where intravascular infusions of EGF resulted in an acute natriuresis and diuresis despite a fall in GFR (14) . Infusion of EGF directly into the renal artery (12.5 gg/h) increased urine flow without an increase in Na' excretion. Intravenous EGF infusion (125 tg/h) resulted in a 500% increase in urine flow and doubled Na' excretion, while 5"Cr EDTA-estimated GFR and renal plasma flow (125paraaminohippurate clearance) both gradually fell. These effects of EGF infusion in the unanesthetized animal suggest that the EGF-induced diuresis (and natriuresis) is due to a tubular and not a hemodynamic effect of EGF. Our studies support this inference and suggest the CCT is at least one of the segments involved in this diuretic response of the intact animal to EGF. Whether blood EGF concentrations vary in response to changes in water balance or volume status is unknown, so a physiologic role for EGF in modulating water flow in vivo remains to be determined.
In order to further define the role of EGF in the kidney, one must determine the intrarenal segmental distribution of EGF receptors, the cellular effects of EGF in the segments bearing specific EGF receptors, and the physiologic parameters that regulate delivery of EGF to these segments. The present studies help address the first two points. We have demonstrated specific '25I-EGF binding to microdissected CCTs and a functional effect ofEGF in this segment. Pretreatment of the CCT with picomolar concentrations of EGF results in rapid depolarization of the CCT and blunts the subsequent hydroosmotic response to vasopressin. It is unlikely that these effects are nonspecific or due to a toxic effect of the EGF preparation for several reasons. First, this preparation of EGF is highly pure as determined by amino acid analysis.4 In addition, application of EGF from the lumen, at a concentration equivalent to the highest concentration of EGF tested in the bath (25 nM EGF), had no effect on either V, or Lp. If the effects of EGF were not receptor mediated but mediated by some nonspecific toxic effect of EGF, one would expect equal activity from the lumen as from the bath. Together with the demonstration ofspecific EGF binding, these results are highly suggestive that these effects are mediated by a specific EGF receptor.
The high-potency, dose-dependent effects of EGF on the CCT are also consistent with a receptor-mediated process. Al- 4 . Mouse EGF is devoid of alanine, phenylalanine, and lysine residues (25) . Each preparation is extensively characterized by amino acid analysis and shown free of these amino acid residues before use.
though the presence of a specific glycoprotein EGF receptor in whole kidney has been demonstrated (10), the intrarenal distribution of this receptor is unknown. EGF receptors have also been demonstrated in cultured cells derived from the proximal tubule, inner medullary collecting duct, and papillary collecting duct (1 1-13) . The present studies suggest that specific EGF receptors also exist in the CCT. Furthermore, to our knowledge, these results represent the first demonstration of function-linked EGF receptors in a noncultured renal epithelium.
To characterize the mechanism of the EGF-mediated inhibition of AVP-stimulated water transport in the CCT, we examined its effect on CcAMP-induced water reabsorption. The binding of vasopressin to its receptor in the CCT is linked to stimulation of adenylate cyclase and cAMP accumulation via a process modulated by guanine nucleotide binding proteins (30) (31) (32) (33) . This cascade can be bypassed by the addition of cell permeable cAMP analogues, such as CcAMP. This allows one to distinguish events modulating cAMP accumulation from events resulting from these high intracellular cAMP levels. In the CCT 0.1 mM CcAMP results in a comparable increase in Lp as that seen with 10 ,U/ml AVP. The present studies demonstrate that EGF suppressed both AVP-and CcAMP-stimulated Lp to an equal extent. This suggests that its inhibitory effect is predominantly at a step distal to cAMP generation. These results do not exclude additional effects of EGF, such as downregulation of the AVP receptor, alteration of the AVP receptor affinity for its ligand, or decreased cAMP production per molecule of AVP bound to the CCT. However, the fact that EGF blunts the hydroosmotic effect of maximal concentrations of the phosphodiesterase resistant cAMP analogue, CcAMP, precludes examining these possibilities using Lp as a functional assay. The biochemical events that occur after cAMP generation are less well characterized than those involved in its generation but appear to involve alterations in cytoskeletal elements which results in exocytosis of the putative water channel into the apical cell membrane (32) .
By means of in vitro microperfusion several endogenous inhibitors of vasopressin action in the CCT have been described. These include prostaglandin E2, alpha-2 adrenergic agents, bradykinin, and atrial natriuretic factor (33) (34) (35) (36) . None of these agents inhibits both AVP-and cAMP-stimulated Lp. They therefore appear to act by interfering with cell cAMP accumulation. This is in marked contrast to our results with EGF which also inhibits CcAMP-stimulated Lp. EGF appears to be the first peptide modulator of AVP-stimulated water flow, which acts predominantly at a post-cAMP step.
Multiple cellular actions of EGF have been described (2, 37) . These can be separated into early effects (seen in minutes, including tyrosine kinase activity, increased prostaglandin production, increased cell calcium influx, inositol phosphate production, and stimulation of Na+/H+ exchange) and late effects (may require exposure to EGF for up to 8 h, including increased proto-oncogene transcription, including c-fos, and c-myc, and stimulation of DNA synthesis and cell proliferation). Recently, it has been demonstrated that both the immediate and late cellular effects of EGF are dependent upon the receptor-associated tyrosine kinase activity (37) . Cells transfected with EGF receptors, containing a point mutation which abolishes the receptor tyrosine kinase activity, display normal EGF binding but no calcium transient, stimulation of c-fos transcription, or mitogensis-findings which can be demonstrated in cells transfected with the normal receptor. Thus it appears that tyrosine kinase activity is required for normal transduction of the other cellular effects of EGF. These other cellular effects of EGF are less consistently demonstrable. For example, while it seems likely that EGF stimulates phosphatidyl inositol turnover in the human epidermoid carcinoma cell line, A-43 1, similar findings have not been observed in either Chinese hamster lung or NIH 3T3 fibroblasts (29, 38, 39) .
To further characterize the signal transduction pathway mediating the action of EGF on vasopressin-stimulated osmotic water flow, we used the cyclooxygenase inhibitor, INDO, and the protein kinase C inhibitor, STSP. In the both the isolated perfused stomach preparation and Madin-Darby canine kidney cells, EGF increases PGE2 production (40, 41) . Since PGE2 has been shown to decrease V1 and inhibit the hydroosmotic effect of AVP in the CCT (26, 33, 42) It is also possible that EGF levels in renal peritubular vessels or renal interstitium are higher than levels in systemic venous blood. This would require that renal prepro-EGF be processed to EGF and released into the peritubular capillaries or renal interstitium. Measurement of renal arterial, venous, and interstitial (lymphatic) EGF concentrations would be required to document this possibility.
In conclusion, we have described potent effects of picomolar EGF on the isolated perfused rabbit CCT. EGF inhibits both AVP-and cAMP-stimulated water flow. It also causes the spontaneously negative Vt of the CCT to depolarize towards zero or become positive, suggesting effects on ion transport. These findings are observed only with EGF in the bath but not the lumen. These results coupled with the demonstration of specific EGF binding sites argue for the presence of specific basolateral EGF receptors in the CCT. Finally, the EGF-mediated effects on AVP-stimulated osmotic water flow can be reversed by STSP, suggesting that protein kinase C may be involved. The potent and rapid effects of EGF in the CCT raise the possibility that in addition to its role as a mitogen EGF could play a role in regulating renal function.
